David Nolan

HLA-B*5701 Screening for Hypersensitivity to Abacavir

S. Mallal, Elizabeth J. Phillips, Giampiero Carosi et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text

Life Sciences, Dermatology, Immunology +15

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

S. Mallal, David Nolan, Campbell S. Witt et al. · The Lancet · 2002 · 1.4K citations

Life Sciences, Immunology, Infectious Diseases +12

Predisposition to abacavir hypersensitivity conferred by <i>HLA-B</i> * <i>5701</i> and a haplotypic <i>Hsp70-Hom</i> variant

A. Martin, David Nolan, Silvana Gaudieri et al. · Proceedings of the National Academy of Sciences · 2004 · 443 citations · Full text

Life Sciences, Genetics, Immunology +15

Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

Diana Chessman, Lyudmila Kostenko, Tessa Lethborg et al. · Immunity · 2008 · 336 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

A. Martin, David Nolan, Ian James et al. · AIDS · 2004 · 316 citations

Life Sciences, Immunology, Pharmacology +16